Barani Suganya, Bhatnagar Tarun, Natarajan Meenakumari, Gayathri Kumari, Sonekar Harshal Bhimrao, Sasidharan Akhil, Selvavinayagam T S, Bagepally Bhavani Shankara
Directorate of Public Health and Preventive Medicine, Tamil Nadu, India.
ICMR-National Institute of Epidemiology, Chennai, India.
Clin Epidemiol Glob Health. 2022 Jan-Feb;13:100943. doi: 10.1016/j.cegh.2021.100943. Epub 2022 Jan 3.
The EQ-5D-5L questionnaire is a tool that is a very generic and preference-based instrument to describe the health-related quality of life. We have generated the stratified index utility value for the Tamil Nadu population and compared the utility values based on socio-demographic and clinical characteristics.
We conducted a community-based analytical cross-sectional study using telephonic interviews from November 2020 till December 2020 among individuals aged 18 years and above who were infected by the coronavirus confirmed with an RT-PCR within 30 days in Tamil Nadu State. EQ-5D-5L profile, socio-demographic and clinical characteristics of the study participants were collected and analysed.
We interviewed 372 participants, with 57.5% were males, and their mean age was 44.5 ± 15.3 years. About 40% of participants reported as having comorbidities, such as diabetes (19.4%), hypertension (12.4%), heart disease (2.4%), kidney disease (0.8%) and others. The mean EQ-5D utility score was 0.925 ± 0.150, and the mean EQ-VAS was 90.68 ± 11.81. Overall, men had a higher utility value (0.938 ± 0.130) than women, (0.907 ± 0.170). Individuals with comorbidities, requiring longer hospitalisation were having lower utility scores than their counterparts.
We report the EQ-5D-5L utility values for the COVID-19 illness. These values would help to estimate quality-adjusted life years in health economic evaluation studies.
EQ-5D-5L问卷是一种非常通用的、基于偏好的工具,用于描述与健康相关的生活质量。我们生成了泰米尔纳德邦人群的分层指数效用值,并根据社会人口统计学和临床特征对效用值进行了比较。
我们于2020年11月至2020年12月进行了一项基于社区的分析性横断面研究,通过电话访谈泰米尔纳德邦18岁及以上的个体,这些个体在30天内通过RT-PCR确诊感染了冠状病毒。收集并分析了研究参与者的EQ-5D-5L概况、社会人口统计学和临床特征。
我们采访了372名参与者,其中57.5%为男性,他们的平均年龄为44.5±15.3岁。约40%的参与者报告患有合并症,如糖尿病(19.4%)、高血压(12.4%)、心脏病(2.4%)、肾病(0.8%)等。EQ-5D效用评分的平均值为0.925±0.150,EQ-VAS的平均值为90.68±11.81。总体而言,男性的效用值(0.938±0.130)高于女性(0.907±0.170)。患有合并症、需要更长住院时间的个体的效用评分低于其同龄人。
我们报告了COVID-19疾病的EQ-5D-5L效用值。这些值将有助于在健康经济评估研究中估计质量调整生命年。